Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $41.46 million. The enterprise value is $34.65 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 55.27 million shares outstanding. The number of shares has increased by 58.46% in one year.
| Current Share Class | 55.27M |
| Shares Outstanding | 55.27M |
| Shares Change (YoY) | +58.46% |
| Shares Change (QoQ) | +29.32% |
| Owned by Insiders (%) | 6.60% |
| Owned by Institutions (%) | 26.07% |
| Float | 44.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 13.55 |
| PB Ratio | 3.50 |
| P/TBV Ratio | 3.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.04 |
| Quick Ratio | 3.67 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -215.41% and return on invested capital (ROIC) is -124.76%.
| Return on Equity (ROE) | -215.41% |
| Return on Assets (ROA) | -111.54% |
| Return on Invested Capital (ROIC) | -124.76% |
| Return on Capital Employed (ROCE) | -178.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$396,093 |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.29% in the last 52 weeks. The beta is -4.99, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | -4.99 |
| 52-Week Price Change | -64.29% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 57.08 |
| Average Volume (20 Days) | 1,084,423 |
Short Selling Information
The latest short interest is 118,205, so 0.21% of the outstanding shares have been sold short.
| Short Interest | 118,205 |
| Short Previous Month | 134,339 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.63M |
| Pretax Income | -17.47M |
| Net Income | -21.39M |
| EBITDA | -20.36M |
| EBIT | -21.63M |
| Earnings Per Share (EPS) | -$0.51 |
Full Income StatementBalance Sheet
The company has $7.52 million in cash and $715,000 in debt, giving a net cash position of $6.81 million or $0.12 per share.
| Cash & Cash Equivalents | 7.52M |
| Total Debt | 715,000 |
| Net Cash | 6.81M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 11.84M |
| Book Value Per Share | 0.21 |
| Working Capital | 6.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.54 million and capital expenditures -$2.59 million, giving a free cash flow of -$20.13 million.
| Operating Cash Flow | -17.54M |
| Capital Expenditures | -2.59M |
| Free Cash Flow | -20.13M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
